| Direktif | Tarikh |
| 20 Disember 2021 |
Direktif untuk semua produk yang mengandungi decitabine: Pengemaskinian sisip bungkusan dengan maklumat keselamatan berkaitan risiko differentiation syndrome
- Posted By Lisa Assakina
- Hits: 4836
 |
 |
 |
 |
National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti (Jalan Prof Diraja Ungku Aziz), 46200 Petaling Jaya, Selangor, Malaysia.
- Email: npra@npra.gov.my
- Phone: +603-7883 5400
- Fax: +603-7956 2924, +603-7956 7075
 |
 |
 |
 |
More Links
DISCLAIMER
The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.
Mobile Web :
Site Last Modified
- Last Modified: Thursday 23 March 2023, 12:08:56.